Several normal and pathological antigen-driven immune responses are associated with limited TCR usage. CDR3 sequence and to some extent length represent clonal markers which can be used to follow the course of an immune response. We investigated whether differences exist in the CDR3 length distribution in the CD4 versus CD8 populations which might reflect the HLA class restriction of the T cell subpopulation. We showed that the range is similar in both the CD4 and CD8 populations for most BV families. Differences exist between CDR3 length distributions of adult versus cord blood CD4 and CD8 T cells. The percentage expressing CDR3 of 10 amino acids or more across all BV families was significantly lower in the cord blood T cells compared to the adults for both CD4 and CD8 populations. This is likely to reflect either differences in the development of the T cell population such as increased N region length post-partum or may be the result of foreign antigen exposure. To address this issue, samples of TCRBV sequences from cord and adult T cell populations were compared. No significant differences were found in either exonucleolytic removal or N region addition between the adult and cord blood samples suggesting that the population shift is the result of antigen exposure. No spectratype distortions existed for any BV family in the adult or cord blood CD4 populations; however, distortions were seen in CD8 populations from all the adults and much less frequently in the cord blood T cells. We investigated the ability to detect clonality at frequencies that one would expect to find antigen-specific T cells in the peripheral repertoire. It was possible to identify a clone at a frequency of 0.1% in a polyclonal CD4 population. This frequency corresponds to that of some individual clones after antigen-driven T cell expansion and establishes parameters within which T cell immune responses may be tracked ex vivo.
Introduction
Antigen recognition by the majority of peripheral blood T cells in humans and mice involves the engagement of the cell surface αβ TCR with peptide-MHC class I (CD8 T cells) or class II (CD4 T cells) complexes (1) . The α and β chains of the TCR are formed by the joining of germline-encoded variable (V), diversity (D) (in β chains) and joining (J) region segments during the process of rearrangement at the TCR loci. An additional process creating N region diversity involves the non-germline encoded addition of randomly selected nucleotides which are added at the 3Ј end of the V regions, 5Ј and 3Ј ends of the D regions, and the 5Ј end of the J region segments by the enzyme terminal deoxynucleotidyl transferase (TdT) (2) (3) (4) (5) . Together with nucleotide removal at Correspondence to: M. A. Hall Transmitting editor: E. Simpson Received 8 September 1997, accepted 9 June 1998 the termini of the V, D and J regions, productively rearranged TCR β or α chains will be expressed as an αβ heterodimer at the surface of the T cell. The combinatorial possibilities offered by multiple tandemly arranged BV, BD and BJ segments together with the processes described above ensures a highly diverse TCRB repertoire with maximum hypervariability at the V-D-J junctions. This region encodes the complementarity determining region (CDR) 3 of the TCR β chain which has been recently shown to interact physically with the complex of HLA class I and bound antigenic peptide. A similar topology is assumed for HLA class II and peptide (6, 7) . A number of normal and pathological antigen-driven immune responses in humans and rodents appear to be associated with limited TCR usage (8) (9) (10) (11) . The reasons for this are not understood but may relate to a requirement for high-affinity TCR-MHC-peptide interactions in certain immune recognition events. In such responses the CDR3 sequence is likely to be critical to the interaction of a T cell population with peptide-MHC complexes. The CDR3 sequence and to some extent its length represents a clonal marker which can be used to follow the course of an immune response (12) . In many immune-mediated diseases, the target antigens and restricting elements for pathological T cells have yet to be identified. One difficulty has been the relatively low frequencies of antigen-specific T cells which may be associated with an immune response (13) . Thus the identification of CDR3 components is a powerful approach to further our understanding of the nature of T cell involvement in normal immune responses and in immune-mediated diseases. A semi-automated approach to quantitative CDR3 analysis, which has been termed spectratyping, has been pioneered by a number of investigators and offers a relatively objective approach to the analysis of the T cell repertoire (12, 14, 15) . This method
has not yet been fully tested in terms of the sensitivity of detection of clonally expanded sequences, but has been used to identify specific T cell populations that are altered during the course of disease (16) .
We have shown previously that the TCR β junctional region repertoire of humans is subject to structural constraints associated with J β usage (17) . The CDR3 length distribution differs significantly between receptors which have rearranged to BJ1 versus BJ2 families. It is important to establish whether variation in CDR3 length exists between subsets of human T cells in order to interpret TCR repertoire data from disease and control tissues. There is some evidence in at least one mouse strain, the SJL transgenic for an I-E α gene, that CDR3 length is significantly greater amongst V β 17a CD8 ϩ than CD4 ϩ lymph node T cells (18) . It is possible therefore that the differing CDR3 length distributions represent an adaptation to interaction with either MHC class I or class II peptide complexes with longer CDR3 loops enhancing contact with peptide-MHC class I complexes. We postulated that comparable differences might also exist in the human mature peripheral T cell repertoire and so undertook a comprehensive CDR3 length assay based analysis of cord blood, and adult CD4 and CD8 peripheral blood T cell populations. Three issues were addressed. The first was whether within an individual differences exist in the CDR3 length distribution in the CD4 versus CD8 populations which might reflect the HLA class restriction of the T cell subpopulation. Secondly, we examined whether differences exist between CDR3 length distribution of adult versus cord CD4 and CD8 T cells reflecting development of the human TCR repertoire after foreign antigen exposure. Thirdly, we investigated the frequency and nature of clonal TCR rearrangements in adult and cord blood T cell populations.
Methods

CD4 and CD8 T cell separation
Six healthy adults (age range 21-50) and two cord blood samples were used for the study. Peripheral and cord blood mononuclear cells were isolated from 40 ml whole blood using Lymphoprep (Nycomed, Oslo, Norway). CD4 and CD8 T cells were separated from this population using anti-CD4 and anti-CD8 Dynabeads (Dynal, Oslo, Norway). The population used for the study was obtained by negative selection to avoid any contamination with the double-positive T cell population. The purified populations were tested by cytofluorographic analysis and only samples with Ͼ98% purity were used for subsequent analysis.
CDR3 length analysis
Aliquots of 5ϫ10 6 CD4 and CD8 cells were pelleted, and RNA extraction carried out using standard methods (19) . Total RNA (5 µg) was used for oligo(dT) [12] [13] [14] [15] [16] [17] [18] -primed first-strand cDNA synthesis using MMLV reverse transcriptase (Gibco/ BRL, Paisley, UK). PCR amplification using internal TCR C β primers (5Ј primer 5Ј-AGGACCTGAAAAAGGTGTT and 3Ј primer 5Ј-ATCCTTTCTCTTGACCATG) was carried out on 1 µl of the cDNA first strand mixture to check that the cDNA synthesis had worked. Each first strand was diluted 1:50 with sterile water and 3 µl used for each amplification using primers for TCR BV families 1-24 as described by Maslanka et al. (20) . Each of the BV primers was used with a HEXlabelled CB primer. Amplification was carried out in 25 µl volumes with an initial denaturing step of 2 min at 95°C, followed by 30 cycles of 95°C for 1 min, 59°C for 1 min and 72°C for 1 min, with a final extension step of 7 min. Then 5 µl of the PCR product was electrophoresed on an agarose gel and the concentration of the product adjusted accordingly. For those samples which gave a very weak signal or which gave split peaks in the CDR3 length analysis, the amplifications were repeated using Amplitaq Gold (Perkin-Elmer) following the manufacturer's instructions and/or carrying out a final extension step using 5 mM MgCl 2 for 10 min as previously described (20) .
The CDR3 length analysis was carried out by running the diluted HEX-labelled PCR products on polyacrylamide denaturing gels on an ABI 377 automated DNA sequencer. The 4.25% 1ϫTBE denaturing gels were poured on 12 cm plates as recommended by the manufacturer. The loading cocktail was prepared by mixing 1.5 µl diluted PCR product with 3.5 µl loading buffer (2.5 µl formamide, 0.5 µl blue dextran and 0. 5 µl Genescan 500 TAMRA size standard), heating to 90°C for 5 min then chilling on ice until loading onto the gel. An aliquot of 3 µl of the sample was loaded onto the gel and the samples electrophoresed for 1 h. The sample files for each PCR product were analysed using Genescan software (ABI).
Cloning and sequencing of inverse PCR amplified TCRBV cDNA Full length sequences of rearranged TCRBV transcripts were obtained from T cell RNA of one adult and two cord blood samples by inverse PCR following a previously described protocol (17) . A total of 94 cord-derived and 129 adult TCR sequences were compared.
Direct sequencing of PCR products PCR products were directly sequenced from individuals which were shown to have a specific CDR3 length for a BV family which was Ͼ45% of the total. An aliquot of 5 µl of PCR product was mixed with 10 U (1 µl of 10 ng/µl) exonuclease I and 2 U (1 µl of 2 U/µl) shrimp alkaline phosphatase, and incubated at 37°C for 15 min. The exonuclease I removes residual single-stranded primers and any extraneous singlestranded DNA produced by the PCR. The shrimp alkaline phosphatase removes the remaining dNTPs from the PCR mixture which would interfere with the labelling step of the sequencing process. These two enzymes were heat inactivated by heating to 80°C. Then 10 ng of PCR product was taken for direct sequencing using the Thermosequenase radiolabelled terminator cycle sequencing kit (Amersham, Amersham, UK). Products were run down a conventional 5% polyacrylamide denaturing gel which was dried and exposed to X-ray film overnight. PCR samples representative of polyclonal populations (17%) and expansions (45-95%) were chosen for sequencing as indicated by the spectratyping analysis.
DNA and cell mixing CDR3 analysis
The cell lines Jurkat and MOLT4 were used for the DNA and cell mixing analysis by spectratyping. The TCR sequence and consequently the CDR3 length is known for both cell lines. Jurkat is BV8 and has a CDR3 length of 11 amino acids (CASSFSTCSANYGYTFGSG). MOLT4 is BV2 and also has a CDR3 length of 11 amino acids (CSARESTSDPKNEQFFGPG). Total RNA was isolated from 5ϫ10 7 cells from each T cell line. CD4 T cells (5ϫ10 7 ) were isolated from peripheral blood lymphocytes from a normal individual by negative selection using anti-CD8-labelled Dynabeads. Total RNA was extracted from the cells. First-strand cDNA was synthesized using the method described earlier and the concentration of cDNA measured by UV spectrometry. Cell line cDNA was then mixed into the polyclonal population at a ratio of cell line cDNA:polyclonal cDNA of 0:1000 (pure polyclonal population), 1:999 (0.1%), 2:998 (0.5%), 10:990 (1%), 25:975 (2.5%), 59:950 (5%), 100:900 (10%) and 200:800 (20%). For the cell mixing experiment 5ϫ10 7 cells from both the T cell lines and the polyclonal CD4 cells from a normal individual were isolated. The cells were mixed together in the following ratios of cell:polyclonal CD4 cells of 0:1000 (pure polyclonal population), 1:999 (1000 clonal cells in 1ϫ10 6 polyclonal CD4 cells, 0.1%), 10:990 (10,000 clonal cells in 1ϫ10 6 polyclonal CD4 cells 1%), 50:950 (50,000 clonal cells in 1ϫ10 6 polyclonal CD4 cells, 5%), 100:900 (100,000 clonal cells in 1ϫ10 6 polyclonal CD4 cells, 10%) and 200:800 (200,000 clonal cells in 1ϫ10 6 polyclonal CD4 cells, 20%). Total RNA was extracted from each aliquot of 1ϫ10 6 cells followed by first-strand synthesis using 5 µg total RNA. For both the cell mixing and DNA mixing experiments PCR amplification was carried out on the cDNA using either the BV2 (MOLT4) or BV8 (Jurkat) TCRBV 5Ј primers together with the HEX-labelled TCR C β 3Ј primer for 30 cycles using the protocol described previously. The samples were run on polyacrylamide denaturing gels and analysed as described before, and the contribution made by each clone to the polyclonal population was measured.
Statistical analysis
Spectratyping data for each BV family was tabulated giving a peak area for each CDR3 length measured. The distributions and 18 all show distortions at a particular CDR3 length in the CD8 population compared to the CD4 population. The peak area contributed by the expanded CDR3 peak to the total CDR3 peak area is shown in brackets with an arrow marking the peak. The spectratypes for BV17 shown are from a cord blood sample which indicates no distortion in any of the CDR3 peaks in the CD4 or CD8 population.
were analysed using the t-test comparing CD4 cells with the CD8 cells in both adults and cord blood T cells.
Results
CDR3 length distribution in adult and cord blood samples
In defining the CDR3 region anchor points (amino acids 95-106) the guidelines of Chothia (21) which we and others have used previously were followed (17) . Nucleotide removal and addition was based on germline sequences. The germline sequences were established in the TCR transcripts based on published sequences and the amino acids contributing the NDN addition were calculated. Typical CDR3 spectratypes for human peripheral blood T cell populations are shown in Fig. 1 . The CD4 spectratypes are approximately normally distributed, whereas for the CD8 population shown, three out of the four BV families show evidence of distortions from the normal distribution. The mean CDR3 length for all BV families for the CD4 and CD8 populations studied (five adults and two cord blood T cells included) is shown in Fig. 2 . Data are reported for BV distributions after excluding those with obvious distortions in the CD8 repertoire. The range of CDR3 lengths Mean CDR3 length distribution for the five adults and two cord bloods combined for the CD4 and CD8 T cell populations in BV families 1-24. Some BV families are represented by fewer dots on the graph. This is a result of overlap of the dots in some cases or that the individuals were excluded because they showed significant skewing in the CDR3 distribution.
was similar for all BV families. The general range was 5-15 amino acids, the predominant length of usually 8-10 amino acids suggesting an optimum CDR3 length for interaction with peptide-bound MHC molecules. The range is similar in both the CD4 and CD8 populations for most BV families with a few exceptions. Certain BV families showed a shorter mean CDR3 length. BV4 and BV8 had CDR3 lengths that were shorter than the other BV families in all individuals studied (Fig. 2) . This was observed in both the CD4 and CD8 populations CD4 and CD8 T cell subsets
We next analysed whether any differences existed in CDR3 length distributions between CD4 and CD8 cells which might reflect the fundamental difference in HLA restriction of these subsets. Distributions were calculated as a percentage of the population with a CDR3 ജ10 amino acids. This was chosen to lie just above the mean CDR3 length for the majority of BV families. Only those CD8 populations where there was no evidence of skewed CDR3 distributions were included in the analysis. There was no significant difference in the percentage of CD4 and CD8 T cells expressing CDR3 ജ10 amino acids across the BV families (P ϭ 0.4). This suggests that the CDR3 of CD8 T cells are on average no longer than those of CD4 T cells.
To investigate whether maturational effects on the human TCRBV repertoire result in differences in the CDR3 profile, the cord blood and adult data were compared. The percentage of T cells expressing CDR3 ജ10 amino acids across all BV families was significantly lower in the cord blood T cells compared to the adults. This difference was significant for both the CD8 T cells [mean percent CDR3 ജ10 ϭ 39 (cord blood T cells) versus 51 (adults), P ϭ 0.00001] and the CD4 T cells [mean percent CDR3 ജ10 ϭ 40 (cord blood T cells) versus 50 (adults), P ϭ 0.0004] (Fig. 3) . The minimum and maximum CDR3 lengths are similar in cord blood and adult T cells for all BV families. This implies that there is no intrinsic inability of the recombination machinery in the newborn to create junctional regions equivalent to the adult lengths. However, there is a general increase in CDR3 length as the population of peripheral blood T cells matures. This phenomenon appears to apply to all BV families.
To investigate whether the observed TCRBV CDR3 length disparity reflected differences in the activity or efficiency of exonucleolytic digestion or TdT addition of N region nucleotides during recombination, we studied junctional region sequences from cord blood and adult CD4 and CD8 T cells. There was no significant difference between adult and cord blood in the mean number of amino acids removed (1.42 and 1.1 for the cord bloods, and 1.32 adult) and the number of amino acids comprising NDN addition (5.6 and 5.3 for the cord bloods, and 5.28 adult).
TCRB clonality in cord blood and adult peripheral CD4 and CD8 populations The analyses described above excluded CDR3 distributions which showed evidence of BV repertoire distortions (examples of which are shown in Fig. 1 ). However, these distortions appear to be a key feature of the human TCR repertoire and merit further investigation. We therefore carried out a systematic evaluation of the nature and prevalence of these distortions in CD4 and CD8 populations of normal peripheral adult and cord blood. There were no distortions in the spectratypes for any of the BV families in the adult or cord blood CD4 populations studied. In contrast to the CD4 population, distortions were seen in CD8 T cell subsets from all the adults studied and to a much more limited extent in the cord blood T cells. Distortions within the CD8 T cell compartment were arbitrarily defined as increases in the area of an individual spectratype peak of ജ25% relative to the equivalent length peak of a given TCRBV family in the CD4 compartment. Table 1 summarizes the distortions seen in the CD8 populations for all BV families studied. All the adults and to a much lesser degree both cord blood T cells showed differences between the CD4 and CD8 samples within an individual. Comparing the CD4 and CD8 populations, each adult had between eight and 19 BV families showing distortion in CDR3 length distribution as defined above. This value was much lower in the cord blood samples (two to four BV families).
Having established the presence of distortions in a CD8 repertoire, we analysed the CD8 populations independently to quantitatively estimate TCR messages contributing to individual CDR3 lengths within a spectratype. Only the CD8 families which were defined as having distortions compared with the CD4 population were investigated further. Individual CD8 peaks were expressed as a percentage of total CD8 peak area. None of the cord samples had a single TCRBV family peak represented in the CD8 repertoire at a frequency as high as 32%. However, in the adults individual CDR3 peaks were represented at frequencies as high as 74%. With a few exceptions the cord blood CD8 distribution was similar to the CD4 distribution. One of the adults, the eldest in the study at 50 years (M. S.), had a significant number of expansions in the CD8 repertoire, with 11 BV family peaks represented at a frequency of between 38 and 74%. The rest of the adults had between one and two BV family peaks represented in the CD8 repertoire within this frequency range. Thus not only were cord blood CD8 populations less likely to show spectratype skewing, when it was observed it was of a lower magnitude than that seen in adults.
Direct sequencing of PCR products to estimate levels of oligoclonality To determine whether the CD8 TCR repertoire distortions were the result of the predominance of a clonal TCR message, we directly sequenced BV family-specific PCR products from individuals with spectratype peak distortions over a range of 17 to Ͼ95% of the total distribution for a given BV family. If a clonal sequence dominates the pool of TCR for a particular BV family then it should be possible to discriminate this sequence from the polyclonal background on a sequencing gel. Typical results are shown in Fig. 4 . It was not possible to identify clearly sequences where a single peak was represented at a frequency of Ͻ45% of total. For one sample where a spectratype peak distortion was present at 17% it was not possible to discriminate a clonal sequence from the polyclonal background (data not shown). At 45% the sequence was readable although at some positions we were unable to distinguish between two nucleotides. At ജ74%, the clonal sequence was clearly read. In all instances, the CDR3 length determined from direct sequencing corresponded exactly to the length of the clonal peak determined from the spectratype data, confirming that the clonal sequence was responsible for the distortion.
DNA and cell titration CDR3 analysis
The biological relevance of CD8 T cell RNA expansions is currently unclear. Clonal spectratype distortions could be caused by highly activated clonal T cells or by large numbers of a moderately activated T cell clone. We therefore examined the ability of spectratyping to quantitate the presence of clonal cells within a polyclonal population. We carried out parallel analyses by mixing clonal cells into a polyclonal CD4 T cell population and secondly by adding cDNA from the same clones into polyclonal CD4 cDNA. We used two transformed cells lines to represent activated T cells which produce significant amounts of TCR mRNA of a defined CDR3 length.
The results of titrating MOLT4 and Jurkat cells and cDNA into a polyclonal CD4 population are shown in Figs 5 and 6. The amplification profile showed a typical Gaussian distribution for the CD4 cell population amplified with both the BV2 and the BV8 primers. The addition of clonal cells was readily detected within the peak corresponding to the CDR3 11 for both MOLT4 and Jurkat (Fig. 6) . Figures 5 and 6 show the relative contributions made by cells and cDNA from the T cell clones Jurkat and MOLT4 to the CDR3 11 peak area as a percentage of the total polyclonal population when added at different frequencies. Both T cell lines were detectable at a frequency of 0.1% in the polyclonal population, although the sensitivity of detection was different for the two lines. When Jurkat was present in the polyclonal population at a frequency of 0.1% it only contributed an increase of 0.2% to the total polyclonal population as measured by the area of the CDR3 11 Results from five adults and two cord bloods are shown. Distortions within the CD8 T cell compartment were arbitrarily defined as increases in the area of an individual spectratype peak of ജ25% relative to the equivalent length peak of a given TCRBV family in the CD4 compartment. All the increases seen for particular CDR3 lengths are shown under the headings for the specific BV families. The first value in the percentage column shows the percentage change for that CDR3 length between the CD4 and the CD8 population as represented by peak area, and the second two percentage values (underneath in parentheses) are the actual values for that CDR3 length in the CD4 (first value) and CD8 (second value) population as represented by peak area. Asterisks mark those CD8 CDR3 which have intermediate levels of a single peak (32-37%, single asterisk) and higher levels of a single peak (38-74%, two asterisks).
Fig. 4.
Spectratypes from three individuals with clonal expansions in the CD8 population shown below the results from directly sequencing the BV family-specific PCR products from the same individuals. The clonal expansions range from 45% (BV9) to Ͼ95% (BV6). This latter clonal expansion was found in the peripheral blood CD8 population of a patient with Felty's syndrome who was known to have an expansion of large granular lymphocytes.
peak. This is unlikely to be detected by standard spectratype analysis. MOLT4 contributed an increase of 6% to the total polyclonal population, which although small is accurately measurable by spectratyping. Differences were readily observed when the clones were present at a frequency of ജ1% of the polyclonal population. Jurkat cells contributed an 11.3% increase to the total polyclonal population, whereas MOLT4 contributed a 57.3% increase. Beyond 10% addition of clonal cells, the spectratype is almost completely dominated by the presence of the clonal population. Above this level it would be difficult to accurately discriminate the frequency of activated cells contributing to the polyclonal population. The difference in sensitivity of detection probably reflects a difference in the activation status of the two cell lines. This is further suggested by the cDNA titration experiments shown in Figs 5 and 6. As expected there was effectively no difference between the two cell lines in the sensitivity of detection of cDNA in the polyclonal cDNA. The sensitivity of detection is much lower for the equivalent amount of cDNA as a proportion of the polyclonal population as compared with cells. This is shown best at the 1% level of clone in the polyclonal population. The differential contribution made by a 1% addition of cDNA and a 1% addition of cells is 2.92 versus 11.3% (Jurkat) and 2.94 versus 57.7% (MOLT4), emphasizing the disproportionate level of production of mRNA by the clonal cells (Fig. 5) . Based on the data shown for MOLT4, a population of activated cells at a frequency of between 0.1 and 1% would be easily identified in a polyclonal population by spectratyping. The level of sensitivity of detection would be increased further by analysis of the population with BV-BJ primer combinations.
Discussion
Analysis of the T cell repertoire is important in understanding the relevance of T cells to protective immune responses and immunological disease. Several methods have been adopted for the analysis of variation in the T cell repertoire. Sequencebased analysis has been undertaken by many groups, and has provided information on the amino acid composition and distribution of TCR transcripts in healthy individuals and those with disease (17, (22) (23) (24) . One disadvantage of this approach is that it is subject to stochastic errors when sampling repertoires. Whole repertoire sequencing is useful when studying gross distortions of repertoire associated with conditions such as Felty's syndrome or superantigen related expansions (25) . PCR-based methods have been used in many studies to provide a semi-quantitative analysis of the BV repertoire (26) (27) (28) , although variation in the specificity and efficiency of different primer pairs in amplifying target cDNA has raised questions as to whether the results obtained are truly quantitative. Subtle distortions of TCR repertoire, however, may have functional implications and require analysis. Spectratyping enables the investigator to identify and follow potentially biologically relevant alterations in the T cell repertoire (15) . We therefore set out to establish whether we could predict the number of cells within a polyclonal population responsible for the typical expansions measured by spectratyping, using transformed T cell lines as surrogate antigen-specific T cell clones.
The frequency range of clonal T cells in humans extends from CD8 large granular lymphocytes which may constitute Ͼ95% of the CD8 repertoire within an individual to presumably single post-thymic T cell clones which have yet to meet nonthymic antigen (29) . Thus determining the lower detection limit for clonal TCRB message is important. For MOLT4 in particular, it was possible to identify the clone at a frequency of 0.1% in a polyclonal CD4 population. This frequency may correspond to that demonstrated by some individual clones after antigen-driven expansion of T cells, especially if the cells are highly activated and producing high levels of TCR β chain transcripts (30, 31) . In some cases clonal TCRB sequences from HIV peptide-specific T cells may be represented in cDNA libraries at frequencies of up to 1% (32) . The presence of both MOLT4 and Jurkat, with a specific CDR3 length of 11, was readily detected at the 1% level of clonal cells within a polyclonal population. A large number of distortions in the adult peripheral blood CD8 repertoire fall into the 0.1-1% clonal expansion level and many more exceed this level (see Table 1 ). Thus the potential exists to track specific functionally relevant TCR signatures in vivo and in vitro. One caveat is that the CDR3 length of the clone determines ease of detection in a polyclonal population since expansions at the extremes of the distributions are more easily identified. Further analysis with TCRBJ-specific primers should increase the sensitivity of the assay. Whether a transformed cell line resembles an activated antigen-specific clone in terms of TCR mRNA production and steady-state levels is not known, however, spectratyping has identified antigen-specific T cell clones in multiple sclerosis patients (16) . It is likely therefore that disease-relevant frequencies of at least some activated T cell clones will produce sufficient RNA to be detected. One study reports frequencies of antigen-specific cytotoxic T cells recognizing the influenza matrix protein peptide 58-66 of 1:1500 to 1:58,000 as measured by tetramer staining (33) . These levels fall outside the limits of detection for spectratyping analysis, although if the clones themselves are highly activated they might still be detected using this cDNA-based system. In contrast to this study, other recent studies in the mouse have shown that during acute viral infection there is a massive expansion of antigen-specific CD8 T cells which may contribute from 50-70% of the CD8 repertoire, thus making the possibilities of detection of antigen-specific clones by this method more likely (34, 35) .
Both genetic and environmental factors determine the relative levels of clonotypic T cells in the immune system. Studies in human populations have shown distortions in the frequency of particular clonal populations within CD8 cell subsets in both normal individuals (25, (36) (37) (38) (39) (40) , those showing a response to viral infection (31) , and in the context of immune mediated disease (25, 41) . Significant levels of clonality in CD8 cells have been shown in both young and elderly healthy individuals, with a correlation demonstrated with age (37, 39, 40) . These findings have been confirmed in this study for healthy individuals with a more comprehensive coverage of BV families for CD4 and CD8 T cell repertoires. This comprehensive approach enabled investigation of CDR3 repertoires in cord blood and adult peripheral blood CD4 and CD8 T cells.
Several factors contribute to the final CDR3 length of a given TCRB transcript. These include exonuclease nibbling of 3Ј ends of V β genes, the 5Ј ends of J β genes, and the 5Ј and 3Ј ends of the D region, as well as random N addition of nucleotides at the V-D and D-J junctions probably by TdT (2, 5, 42) . After TCRA rearrangement and successful AB pairing, the processes of positive and negative selection modulate the composition of the peripheral repertoire. In this study we showed that two BV families had shorter junctional region lengths in both the CD4 and CD8 populations than the rest. These were BV4 and BV8. This observation has been made previously for BV4 in a study which investigated just the single BV member families (36) . It is presently unclear whether these differences in distribution reflect the mechanics of rearrangement to particular BV family members or whether structural requirements for MHC-antigen interaction dictate shorter junctional region lengths for these BV families.
It is evident from this study that there is no significant difference in the length of CDR3 between CD4 and CD8 T cells when the population of BV families is analysed as a whole. One of the significant findings of the study was that the proportion of receptors with junctional region lengths of ജ10 amino acids was significantly higher in the adults blood samples compared to the cord blood samples irrespective of whether CD4 or CD8 T cells were considered. The observation of shorter N regions in the early fetal repertoire of BV6 ϩ T cells has been made (43) , but at the cord blood stage of development a comprehensive study on CDR3 length analysis in a large number of BV families has not been previously reported. There are several potential factors which might explain the differences we observed between the adult and cord blood repertoires. These include exposure of the adult repertoire to a range of antigens which the cord T cells have not met, developmental programming of the recombination machinery, and the possibility that CDR3 length may reflect a general phenomenon of ageing of the T cell repertoire which includes such factors as selective activation and survival of specific T cell subsets. We have shown that there is no difference between the cord blood and adult TCR transcripts in the level of exonuclease removal of nucleotides from the V, D and J regions, and in the number of nucleotides added at the NDN region. This implies that the differences seen between the cord blood and adult repertoires are more likely to reflect those T cell subsets that have survived as a result of antigen selection. The time-course for the shift in CDR3 length from cord blood (newborn) through to adulthood is unknown and would need further studies over a number of different age ranges.
Although the diversity created by germline deletion and nontemplate addition of nucleotides during the joining process creates a significant number of structural possibilities, it is clear that there are definite length constraints on the TCR CDR3 in the selected peripheral blood T cell repertoire. This is likely to be dictated by the nature of antigen recognition by MHC-restricted T cells. In knockout mice lacking TdT, their TCR are devoid of N region diversity and therefore germline encoded regions make a relatively greater contribution to TCR variability. Immune responses in these mice are apparently normal (44) and positive selection has been shown to be more efficient (45) . Thus the generation of additional diversity is at the expense of efficiency of interaction with the antigen-MHC complex. Whether CDR3 devoid of N region diversity in humans have a higher affinity for MHC in general is unknown. We show here that the proportion of CDR3 with a length ജ10 amino acids is significantly lower in the cord blood than in the adult repertoire. By analogy with mice, this may result in a greater positive selection efficiency of T cells bearing TCRs with shorter CDR3. There is essentially no difference in the range of CDR3 lengths seen in the adult and cord repertoires for all the BV families studied. Rather is it the proportion of T cells with longer CDR3 that is lower in the cord blood repertoire. At birth TdT activity in the human thymus is low and peaks between 10 and 40 months of age (46) . We show here that as the repertoire ages, the proportion of TCR with longer junctional region lengths increases significantly. Further studies of CD45RA versus CD45RO T cell subsets should give some insight into whether longer CDR3 length distributions are determined purely by up-regulation of TdT activity or whether exposure to foreign and/or self antigens plays a role.
